We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




German Biotech Company to Market Bromodeoxyuridine Antibody Clone

By LabMedica International staff writers
Posted on 17 Nov 2010
A German biotechnology company has been awarded the exclusive right to commercialize the most popular bromodeoxyuridine (BrdU) antibody clone for research applications.

Bromodeoxyuridine (BrdU) is a synthetic thymidine analog that can be incorporated into a cell's DNA when the cell is dividing (during the S-phase of the cell cycle). More...
Antibodies against BrdU that are conjugated to fluorescent markers can be used to label these cells, thereby providing visual evidence of cell division.

The most popular BrdU antibody clone, BU1/75 was developed at the Institute of Cancer Research (London, United Kingdom) where it was initially called ICR1. Exclusive worldwide rights to market this antibody have now been awarded to AbD Serotec, the research and diagnostic antibodies unit of MorphoSys AG (Munich, Germany). The agreement will allow development of diagnostic procedures to proceed in a range of formats suitable for various applications such as ELISA, flow cytometry, and immunohistochemistry.

"With this agreement AbD Serotec will become the sole supplier of this important BrdU antibody, a powerful tool to detect cell proliferation and cell kinetics assays," said Dieter Feger, head of AbD Serotec. "This product complements our comprehensive range of high quality cell biology reagents covering key research areas such as apoptosis, cancer, cell signaling, and cell morphology."

Related Links:
Institute of Cancer Research
MorphoSys AG




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.